Ura, M
4152-A UNVEILING RACIAL DISCREPANCIES IN THE OUTCOMES OF PORTAL VEIN THROMBOSIS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA - A 5-YEAR NATIONWIDE ANALYSIS Fnu Vikash 1 , Sindhu Vikash 1 , Yassine Kilani 2 , Vikash Kumar 3 , Noor Syed 4 , Sobaan Taj 5 , Abu Abbasi 6 , Syeda Ashna Fatima Kamal 7 , Dushyant Dahiya 8 and Sunny Patel 1 , (1)Jacobi Medical Center/Albert Einstein College of Medicine, (2)Lincoln Medical Center, (3)The Brooklyn Hospital Center, (4)Santa Clara Valley Medical Center, (5)Hackensack Meridian Jersey Shore University Medical Center, (6)Loyola University Medical Center, Chicago, IL, (7)Southern Illinois University (SIU)), (8)The University of Kansas School of Medicine Background: Portal vein thrombosis (PVT) is considered a negative prognostic factor in hepatocellular carcinoma (HCC) patients
(PubMed) Hagen TM, Vinarsky V, Wehr CM, Ames BN
It aids in the breakdown of toxic substances and plays a central role in protein synthesis, bile production, and the metabolism of fats and glucose